MedTrace Logo

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies

NCT04298892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-07-01

No results posted yet for this study

Summary

Exploratory multicenter, non-interventional, translational, retrospective and prospective study. All patients with a diagnosis of hematologic disorder or malignancy for whom biological samples and clinical data are available may be included in this study, after obtaining informed consent

Conditions

  • Haematologic Disease
  • Haematological Malignancy

Interventions

OTHER

clinical data and sample collection

Patients with hematologic malignancies and disorders will be asked to donate part of the samples collected as per clinical practice for the management of their disease for the aims of this study. In addition, patients will be asked to donate one oral swab sample, and urine samples. Collection of these additional samples is a non-invasive procedure with no associated risks for patients. Clinical data (demographics including ethnicity, stage of disease, concise treatment history, cytogenetic reports, and molecular data if available, as routinely performed during diagnosis procedures) will be collected.

Sponsors & Collaborators

  • Azienda Unità Sanitaria Locale della Romagna

    collaborator OTHER

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

    lead OTHER

Principal Investigators

  • Giovanni Martinelli, Prof · IRST IRCCS

  • Alessandro Lucchesi, MD · IRST IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-07
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04298892 on ClinicalTrials.gov